341 related articles for article (PubMed ID: 10097126)
1. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
Jeffery KJ; Usuku K; Hall SE; Matsumoto W; Taylor GP; Procter J; Bunce M; Ogg GS; Welsh KI; Weber JN; Lloyd AL; Nowak MA; Nagai M; Kodama D; Izumo S; Osame M; Bangham CR
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3848-53. PubMed ID: 10097126
[TBL] [Abstract][Full Text] [Related]
2. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
[TBL] [Abstract][Full Text] [Related]
3. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; Wucherpfennig KW; Bangham CR; Osame M; Saito M
J Infect Dis; 2007 Dec; 196(12):1761-72. PubMed ID: 18190256
[TBL] [Abstract][Full Text] [Related]
5. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
[TBL] [Abstract][Full Text] [Related]
6. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals.
Sabouri AH; Saito M; Usuku K; Bajestan SN; Mahmoudi M; Forughipour M; Sabouri Z; Abbaspour Z; Goharjoo ME; Khayami E; Hasani A; Izumo S; Arimura K; Farid R; Osame M
J Gen Virol; 2005 Mar; 86(Pt 3):773-781. PubMed ID: 15722539
[TBL] [Abstract][Full Text] [Related]
7. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
8. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
[TBL] [Abstract][Full Text] [Related]
9. Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.
Penova M; Kawaguchi S; Yasunaga JI; Kawaguchi T; Sato T; Takahashi M; Shimizu M; Saito M; Tsukasaki K; Nakagawa M; Takenouchi N; Hara H; Matsuura E; Nozuma S; Takashima H; Izumo S; Watanabe T; Uchimaru K; Iwanaga M; Utsunomiya A; Tabara Y; Paul R; Yamano Y; Matsuoka M; Matsuda F
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33649182
[TBL] [Abstract][Full Text] [Related]
10. Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population.
Schor D; Porto LC; Roma EH; Castro-Alves J; Villela AP; Araújo AQC; Glória Bonecini-Almeida M
Sci Rep; 2023 May; 13(1):7659. PubMed ID: 37169817
[TBL] [Abstract][Full Text] [Related]
11. HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development.
Cilião Alves DC; Haddad R; Rocha-Júnior MC; de Deus Wagatsuma VM; Martelli-Palomino G; Marques AA; Takayanagui OM; Covas DT; Kashima S; Donadi EA
J Gen Virol; 2016 Oct; 97(10):2742-2752. PubMed ID: 27449667
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects.
Assone T; Malta FM; Bakkour S; Montalvo L; Paiva AM; Smid J; de Oliveira ACP; de Toledo Gonçalves F; do Carmo Luiz O; Fonseca LAM; Norris PJ; Casseb J
Virus Res; 2018 Jan; 244():71-74. PubMed ID: 29129607
[TBL] [Abstract][Full Text] [Related]
13. Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.
Treviño A; Vicario JL; Lopez M; Parra P; Benito R; Ortiz de Lejarazu R; Ramos JM; Del Romero J; de Mendoza C; Soriano V
J Neurol; 2013 Oct; 260(10):2551-5. PubMed ID: 23835632
[TBL] [Abstract][Full Text] [Related]
14. Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.
Deschamps R; Béra O; Belrose G; Lezin A; Bellance R; Signate A; Cabre P; Smadja D; Césaire R; Olindo S
Int J Infect Dis; 2010 Nov; 14(11):e986-90. PubMed ID: 20851016
[TBL] [Abstract][Full Text] [Related]
15. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
Best I; López G; Talledo M; MacNamara A; Verdonck K; González E; Tipismana M; Asquith B; Gotuzzo E; Vanham G; Clark D
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1207-12. PubMed ID: 21453202
[TBL] [Abstract][Full Text] [Related]
16. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
17. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
18. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
[TBL] [Abstract][Full Text] [Related]
20. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
